The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$65.84M
$41.63M
$47.40M
$46.85M
$69.03M
$69.42M
Cost of revenue
$32.14M
$35.98M
$39.63M
$39.13M
$36.79M
$38.58M
Gross profit
$33.70M
$5.66M
-
$7.72M
$32.23M
-
R&D
$3.89M
$3.84M
$4.88M
$4.89M
$4.70M
$4.92M
MRVI annual revenue (10-K history)
MARAVAI LIFESCIENCES HOLDINGS, INC. reported annual revenue of $185.74M for fiscal year 2025. That is down 28.3% from $259.19M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $143.14M (FY 2019) to $185.74M. Figures come from the company's audited annual reports as filed with the SEC.